Welcome to LookChem.com Sign In|Join Free

CAS

  • or

4613-71-2

Post Buying Request

4613-71-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4613-71-2 Usage

Description

5-O-Benzoyl-1,2-di-O-acetyl-3-deoxy-D-ribofuranose is a complex organic compound that serves as an important intermediate in the synthesis of various biologically active molecules. It is characterized by its unique structure, which includes a ribofuranose core with specific functional groups that can be further modified or reacted to produce desired compounds.

Uses

Used in Pharmaceutical Industry:
5-O-Benzoyl-1,2-di-O-acetyl-3-deoxy-D-ribofuranose is used as a key reactant for the synthesis of aminooxopyridopyrimidine nucleosides, which possess antitumor cytotoxicity. These nucleosides are promising candidates for the development of new anticancer drugs, as they can potentially inhibit the growth and proliferation of cancer cells.
In the synthesis of these nucleosides, the compound's specific functional groups allow for the formation of essential chemical bonds and the introduction of bioactive moieties. This makes it a valuable component in the development of novel therapeutic agents for cancer treatment.
Additionally, the compound may also find applications in other areas of the pharmaceutical industry, such as the development of antiviral, antibacterial, or antifungal agents, due to its ability to be modified and reacted with various other molecules. However, further research and development would be required to explore these potential applications fully.

Check Digit Verification of cas no

The CAS Registry Mumber 4613-71-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,6,1 and 3 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 4613-71:
(6*4)+(5*6)+(4*1)+(3*3)+(2*7)+(1*1)=82
82 % 10 = 2
So 4613-71-2 is a valid CAS Registry Number.
InChI:InChI=1/C16H18O7/c1-10(17)21-14-8-13(23-16(14)22-11(2)18)9-20-15(19)12-6-4-3-5-7-12/h3-7,13-14,16H,8-9H2,1-2H3/t13-,14+,16?/m0/s1

4613-71-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name [(2S,4R)-4,5-diacetyloxyoxolan-2-yl]methyl benzoate

1.2 Other means of identification

Product number -
Other names 1,2-di-O-acetyl-5-O-benzoyl-3-deoxy-D-erythropentose

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4613-71-2 SDS

4613-71-2Synthetic route

[(3aR,5S,6aR)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl]methyl benzoate
4105-29-7

[(3aR,5S,6aR)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl]methyl benzoate

acetic anhydride
108-24-7

acetic anhydride

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

Conditions
ConditionsYield
Stage #1: [(3aR,5S,6aR)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl]methyl benzoate With acetic acid for 2h; Heating;
Stage #2: acetic anhydride With pyridine; dmap at 20℃; Further stages.;
80%
With sulfuric acid In acetic acid52%
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

2,4-bis(trimethylsiloxy)-5-methylpyrimidine
7288-28-0

2,4-bis(trimethylsiloxy)-5-methylpyrimidine

2'-O-acetyl-5'-O-benzoyl-3'-deoxy-5-methyluridine
143653-60-5

2'-O-acetyl-5'-O-benzoyl-3'-deoxy-5-methyluridine

Conditions
ConditionsYield
With tin(IV) chloride In acetonitrile93%
4-N-Acetylcytosine
14631-20-0

4-N-Acetylcytosine

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

3'-deoxycytidine
7057-33-2

3'-deoxycytidine

Conditions
ConditionsYield
Stage #1: 4-N-Acetylcytosine; 5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose With benzenesulfonamide In acetonitrile for 1h; Heating;
Stage #2: With trimethylsilyl trifluoromethanesulfonate at 20℃; for 5h;
Stage #3: With ammonium hydroxide In tetrahydrofuran; methanol at 50℃; for 6h; Further stages.;
90%
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

2-O-acetyl-5-O-benzoyl-3-deoxy-β-D-erythro-pentofuranosyl azide

2-O-acetyl-5-O-benzoyl-3-deoxy-β-D-erythro-pentofuranosyl azide

Conditions
ConditionsYield
With trimethylsilylazide; tin(IV) chloride In dichloromethane at 23℃; for 12h; azidation;74%
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

N6-isobutyrylaminocytosine
97626-98-7

N6-isobutyrylaminocytosine

2'-O-Acetyl-5'-O-benzoyl-4-N-isobutyryl-3'-deoxycytidine
159217-63-7

2'-O-Acetyl-5'-O-benzoyl-4-N-isobutyryl-3'-deoxycytidine

Conditions
ConditionsYield
With tin(IV) chloride In 1,2-dichloro-ethane at 27℃; for 20h;62%
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

C6H2ClN5
1343405-24-2

C6H2ClN5

C20H16ClN5O5
1343405-28-6

C20H16ClN5O5

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In acetonitrile for 1h; Reflux;61%
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

5-methyltetrazole
4076-36-2

5-methyltetrazole

Benzoic acid (2S,4R,5R)-4-acetoxy-5-(5-methyl-tetrazol-2-yl)-tetrahydro-furan-2-ylmethyl ester

Benzoic acid (2S,4R,5R)-4-acetoxy-5-(5-methyl-tetrazol-2-yl)-tetrahydro-furan-2-ylmethyl ester

Conditions
ConditionsYield
In ethylenediamine for 48h;54%
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

2H-tetrazole
288-94-8

2H-tetrazole

Benzoic acid (2S,4R,5R)-4-acetoxy-5-tetrazol-2-yl-tetrahydro-furan-2-ylmethyl ester

Benzoic acid (2S,4R,5R)-4-acetoxy-5-tetrazol-2-yl-tetrahydro-furan-2-ylmethyl ester

Conditions
ConditionsYield
In ethylenediamine for 48h;51%
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

N-(6,8-dioxo-7-(4-(trifluoromethyl)benzyl)-6,7,8,9-tetrahydro-1H-purin-2-yl)acetamide

N-(6,8-dioxo-7-(4-(trifluoromethyl)benzyl)-6,7,8,9-tetrahydro-1H-purin-2-yl)acetamide

((2S,4R,5R)-5-(2-acetamido-6,8-dioxo-7-(4-(trifluoromethyl)benzyl)-1,6,7,8-tetrahydro-9H purin-9-yl)-4-acetoxytetrahydrofuran-2-yl)methyl benzoate

((2S,4R,5R)-5-(2-acetamido-6,8-dioxo-7-(4-(trifluoromethyl)benzyl)-1,6,7,8-tetrahydro-9H purin-9-yl)-4-acetoxytetrahydrofuran-2-yl)methyl benzoate

Conditions
ConditionsYield
Stage #1: 5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose; N-(6,8-dioxo-7-(4-(trifluoromethyl)benzyl)-6,7,8,9-tetrahydro-1H-purin-2-yl)acetamide With N,O-bis-(trimethylsilyl)-acetamide In 1,2-dichloro-ethane at 80℃; for 0.5h; Inert atmosphere;
Stage #2: With trimethylsilyl trifluoromethanesulfonate In 1,2-dichloro-ethane at 80℃; for 3h;
11%
(Ac)G(TMS)2
42890-94-8

(Ac)G(TMS)2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

A

N2-acetyl-2'-O-acetyl-5'-O-benzoyl-3'-deoxyguanosine

N2-acetyl-2'-O-acetyl-5'-O-benzoyl-3'-deoxyguanosine

B

Benzoic acid (2S,4R,5R)-4-acetoxy-5-(2-acetylamino-6-oxo-1,6-dihydro-purin-7-yl)-tetrahydro-furan-2-ylmethyl ester

Benzoic acid (2S,4R,5R)-4-acetoxy-5-(2-acetylamino-6-oxo-1,6-dihydro-purin-7-yl)-tetrahydro-furan-2-ylmethyl ester

Conditions
ConditionsYield
Yield given. Yields of byproduct given;
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

5-phenyl-2H-1,2,3,4-tetrazole
18039-42-4

5-phenyl-2H-1,2,3,4-tetrazole

Benzoic acid (2S,4R,5R)-4-acetoxy-5-(5-phenyl-tetrazol-2-yl)-tetrahydro-furan-2-ylmethyl ester

Benzoic acid (2S,4R,5R)-4-acetoxy-5-(5-phenyl-tetrazol-2-yl)-tetrahydro-furan-2-ylmethyl ester

Conditions
ConditionsYield
With tin(IV) chloride 1.) acetonitrile, 0 deg C, 1 h, 2.) 50 deg C, 2 h; Yield given. Multistep reaction;
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

4-amino-8H-pyrido[2,3-d]pyrimidin-5-one
306960-30-5

4-amino-8H-pyrido[2,3-d]pyrimidin-5-one

A

benzoic acid 4-acetoxy-5-(4-amino-5-oxo-5H-pyrido[2,3-d]pyrimidin-8-yl)-tetrahydro-furan-2-ylmethyl ester
1053253-53-4

benzoic acid 4-acetoxy-5-(4-amino-5-oxo-5H-pyrido[2,3-d]pyrimidin-8-yl)-tetrahydro-furan-2-ylmethyl ester

B

benzoic acid 4-acetoxy-5-(4-amino-5-oxo-5H-pyrido[2,3-d]pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl ester

benzoic acid 4-acetoxy-5-(4-amino-5-oxo-5H-pyrido[2,3-d]pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl ester

Conditions
ConditionsYield
Stage #1: 4-aminopyrido[2,3-d]pyrimidin-5(8H)-one With N,O-bis-(trimethylsilyl)-acetamide In 1,2-dichloro-ethane at 75℃; for 2h;
Stage #2: 5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose With trimethylsilyl trifluoromethanesulfonate In 1,2-dichloro-ethane for 72h; Vorbrueggen reaction; Heating; Further stages.;
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

4-amino-5-oxo-8-(3-deoxy-β-D-ribofuranosyl)pyrido[2,3-d]pyrimidine

4-amino-5-oxo-8-(3-deoxy-β-D-ribofuranosyl)pyrido[2,3-d]pyrimidine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: N,O-bis(trimethylsilyl)acetamide / 1,2-dichloro-ethane / 2 h / 75 °C
1.2: trimethylsilyl triflate / 1,2-dichloro-ethane / 72 h / Heating
2.1: NH3 / methanol / 20 h / 20 °C
View Scheme
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

Benzoic acid (2S,4R,5S)-4-acetoxy-5-azido-tetrahydro-furan-2-ylmethyl ester

Benzoic acid (2S,4R,5S)-4-acetoxy-5-azido-tetrahydro-furan-2-ylmethyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 74 percent / Me3SiN3 / SnCl4 / CH2Cl2 / 12 h / 23 °C
2: SnCl4 / Me3SiOAc / CH2Cl2 / 192 h / 23 °C
View Scheme
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

3'-deoxycytidine
7057-33-2

3'-deoxycytidine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 62 percent / SnCl4 / 1,2-dichloro-ethane / 20 h / 27 °C
2: 98 percent / NH3 / methanol / 12 h / 25 °C
View Scheme
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

4-(N-Isobutyryl)-3'-deoxycytidine
159217-64-8

4-(N-Isobutyryl)-3'-deoxycytidine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 62 percent / SnCl4 / 1,2-dichloro-ethane / 20 h / 27 °C
2: 98 percent / NH3 / methanol / 12 h / 25 °C
3: 77 percent / dimethylformamide / 18 h / 25 °C
View Scheme
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

4-(N-Isobutyryl)-5'-O-(4,4'-dimethoxytrityl)-3'-deoxycytidine
159217-65-9

4-(N-Isobutyryl)-5'-O-(4,4'-dimethoxytrityl)-3'-deoxycytidine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 62 percent / SnCl4 / 1,2-dichloro-ethane / 20 h / 27 °C
2: 98 percent / NH3 / methanol / 12 h / 25 °C
3: 77 percent / dimethylformamide / 18 h / 25 °C
4: 84 percent / pyridine / 24 h / 25 °C
View Scheme
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

4-(N-Isobutyryl)-5'-O-(4,4'-dimethoxytrityl)-3'-deoxycytidine 2'-O-(2-cyanoethyl N,N-diisopropylphosphoramidite)

4-(N-Isobutyryl)-5'-O-(4,4'-dimethoxytrityl)-3'-deoxycytidine 2'-O-(2-cyanoethyl N,N-diisopropylphosphoramidite)

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 62 percent / SnCl4 / 1,2-dichloro-ethane / 20 h / 27 °C
2: 98 percent / NH3 / methanol / 12 h / 25 °C
3: 77 percent / dimethylformamide / 18 h / 25 °C
4: 84 percent / pyridine / 24 h / 25 °C
5: 86 percent / diisopropylammonium tetrazolide / CH2Cl2 / 7 h / 25 °C
View Scheme
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

3'-deoxy-5'-O-dimethoxytrityl-5-methyluridine
143653-61-6

3'-deoxy-5'-O-dimethoxytrityl-5-methyluridine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 93 percent / SnCl4 / acetonitrile
2: 94 percent / K2CO3, MeOH / Heating
3: 81 percent / pyridine
View Scheme
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

Diisopropyl-phosphoramidous acid (2R,3R,5S)-5-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-2-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yl ester 2-cyano-ethyl ester
142103-12-6

Diisopropyl-phosphoramidous acid (2R,3R,5S)-5-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-2-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yl ester 2-cyano-ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 93 percent / SnCl4 / acetonitrile
2: 94 percent / K2CO3, MeOH / Heating
3: 81 percent / pyridine
4: 66 percent / iPr2NEt / tetrahydrofuran
View Scheme
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

3'-deoxy-5-methyluridine
7084-29-9

3'-deoxy-5-methyluridine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 93 percent / SnCl4 / acetonitrile
2: 94 percent / K2CO3, MeOH / Heating
View Scheme
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

C8H13N3O2Si

C8H13N3O2Si

{(2S,4R,5R)-4-(acetyloxy)-5-[3-(aminocarbonyl)-2-oxo-1(2H)-pyrazinyl]tetrahydro-2-furanyl}methyl benzoate
499785-77-2

{(2S,4R,5R)-4-(acetyloxy)-5-[3-(aminocarbonyl)-2-oxo-1(2H)-pyrazinyl]tetrahydro-2-furanyl}methyl benzoate

Conditions
ConditionsYield
With tin(IV) chloride In acetonitrile at 20℃; for 0.5h;
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

5-aminothaizolo<4,5-d>pyrimidine-2,7(3H,6H)-dione
30161-97-8

5-aminothaizolo<4,5-d>pyrimidine-2,7(3H,6H)-dione

[(2S,4R,5R)-4-acetoxy-5-(5-amino-2,7-dioxo-6H-thiazolo[4,5-d]pyrimidin-3-yl)tetrahydrofuran-2-yl]methyl benzoate

[(2S,4R,5R)-4-acetoxy-5-(5-amino-2,7-dioxo-6H-thiazolo[4,5-d]pyrimidin-3-yl)tetrahydrofuran-2-yl]methyl benzoate

Conditions
ConditionsYield
Stage #1: 5-aminothiazolo<4,5-d>pyrimidine-2,7(3H,6H)-dione With N,O-bis-(trimethylsilyl)-acetamide In acetonitrile at 20 - 70℃; for 0.5h; Inert atmosphere;
Stage #2: 5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose With trimethylsilyl trifluoromethanesulfonate In acetonitrile at 70℃; for 14h; Inert atmosphere;
5.7 g
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

5-amino-3-[(2R,3R,5S)-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6H-thiazolo[4,5-d]pyrimidine-2,7-dione

5-amino-3-[(2R,3R,5S)-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6H-thiazolo[4,5-d]pyrimidine-2,7-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: N,O-bis-(trimethylsilyl)-acetamide / acetonitrile / 0.5 h / 20 - 70 °C / Inert atmosphere
1.2: 14 h / 70 °C / Inert atmosphere
2.1: potassium carbonate / methanol / 3.5 h / 20 °C
View Scheme
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

[(2S,4R,5R)-5-(5-amino-2,7-dioxo-6H-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]methyl benzoate

[(2S,4R,5R)-5-(5-amino-2,7-dioxo-6H-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]methyl benzoate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: N,O-bis-(trimethylsilyl)-acetamide / acetonitrile / 0.5 h / 20 - 70 °C / Inert atmosphere
1.2: 14 h / 70 °C / Inert atmosphere
2.1: potassium carbonate / methanol / 3.5 h / 20 °C
View Scheme
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

5-amino-3-[(2R,3R,5S)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-hydroxy-tetrahydrofuran-2-yl]-6H-thiazolo[4,5-d]pyrimidine-2,7-dione

5-amino-3-[(2R,3R,5S)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-hydroxy-tetrahydrofuran-2-yl]-6H-thiazolo[4,5-d]pyrimidine-2,7-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: N,O-bis-(trimethylsilyl)-acetamide / acetonitrile / 0.5 h / 20 - 70 °C / Inert atmosphere
1.2: 14 h / 70 °C / Inert atmosphere
2.1: potassium carbonate / methanol / 3.5 h / 20 °C
3.1: 1H-imidazole / Petroleum ether; N,N-dimethyl-formamide / 2 h / 20 °C
View Scheme
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

5-amino-3-[(2R,5S)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-oxo-tetrahydrofuran-2-yl]-6H-thiazolo[4,5-d]pyrimidine-2,7-dione

5-amino-3-[(2R,5S)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-oxo-tetrahydrofuran-2-yl]-6H-thiazolo[4,5-d]pyrimidine-2,7-dione

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: N,O-bis-(trimethylsilyl)-acetamide / acetonitrile / 0.5 h / 20 - 70 °C / Inert atmosphere
1.2: 14 h / 70 °C / Inert atmosphere
2.1: potassium carbonate / methanol / 3.5 h / 20 °C
3.1: 1H-imidazole / Petroleum ether; N,N-dimethyl-formamide / 2 h / 20 °C
4.1: Dess-Martin periodane / tetrahydrofuran / 2 h / 20 °C
View Scheme
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

[(2S,4R,5R)-5-(5-amino-2,7-dioxo-6H-thiazolo[4,5-d]pyrimidin-3-yl)-4-phenoxycarbothioyloxy-tetrahydrofuran-2-yl]methyl benzoate

[(2S,4R,5R)-5-(5-amino-2,7-dioxo-6H-thiazolo[4,5-d]pyrimidin-3-yl)-4-phenoxycarbothioyloxy-tetrahydrofuran-2-yl]methyl benzoate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: N,O-bis-(trimethylsilyl)-acetamide / acetonitrile / 0.5 h / 20 - 70 °C / Inert atmosphere
1.2: 14 h / 70 °C / Inert atmosphere
2.1: potassium carbonate / methanol / 3.5 h / 20 °C
3.1: dmap / dichloromethane / 20 °C
View Scheme
5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose
4613-71-2

5-O-benzoyl-3-deoxy-1,2-di-O-acetyl-α,β-D-erythro-pentofuranose

[(2S,4R,5R)-5-(5-amino-2,7-dioxo-6H-thiazolo[4,5-d]pyrimidin-3-yl)-4-(2-methylallyl)tetrahydrofuran-2-yl]methyl benzoate

[(2S,4R,5R)-5-(5-amino-2,7-dioxo-6H-thiazolo[4,5-d]pyrimidin-3-yl)-4-(2-methylallyl)tetrahydrofuran-2-yl]methyl benzoate

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: N,O-bis-(trimethylsilyl)-acetamide / acetonitrile / 0.5 h / 20 - 70 °C / Inert atmosphere
1.2: 14 h / 70 °C / Inert atmosphere
2.1: potassium carbonate / methanol / 3.5 h / 20 °C
3.1: dmap / dichloromethane / 20 °C
4.1: 2,2'-azobis(isobutyronitrile) / toluene / 4 h / 80 °C / Inert atmosphere
4.2: 2 h / 20 °C / Inert atmosphere
View Scheme

4613-71-2Relevant articles and documents

Deoxygenation of 5-O-benzoyl-1,2-isopropylidene-3-O-imidazolylthiocarbonyl-α-d-xylofuranose using dimethyl phosphite: an efficient alternate method towards a 3′-deoxynucleoside glycosyl donor

Zlatev, Ivan,Vasseur, Jean-Jacques,Morvan, Fran?ois

, p. 3288 - 3290 (2008/09/20)

An efficient radical deoxygenation reaction of thiocarbonylimidazolyl activated glycoside analogue using dimethyl phosphite as hydrogen source and radical chain carrier was performed as a key step in a multi step synthesis towards a common 3-deoxy glycosyl donor for 3′-deoxynucleosides. This method has safety and cost advantages compared to the generally used radical reduction reagents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4613-71-2